GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 54 filers reported holding GENERATION BIO CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,720,000 | +3.7% | 1,324,275 | 0.0% | 0.44% | +65.2% |
| Q4 2021 | $9,376,000 | -71.8% | 1,324,275 | 0.0% | 0.26% | -68.0% |
| Q3 2021 | $33,200,000 | -23.4% | 1,324,275 | -17.8% | 0.83% | -24.9% |
| Q2 2021 | $43,342,000 | -5.5% | 1,611,214 | 0.0% | 1.10% | -19.5% |
| Q1 2021 | $45,855,000 | +0.4% | 1,611,214 | 0.0% | 1.37% | +1.0% |
| Q4 2020 | $45,678,000 | -8.3% | 1,611,214 | 0.0% | 1.35% | -39.3% |
| Q3 2020 | $49,803,000 | +47.2% | 1,611,214 | 0.0% | 2.23% | +11.4% |
| Q2 2020 | $33,835,000 | – | 1,611,214 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $43,961,000 | 4.85% |
| GREAT POINT PARTNERS LLC | 825,077 | $4,381,000 | 1.06% |
| HighVista Strategies LLC | 248,994 | $1,322,000 | 0.76% |
| Artal Group S.A. | 2,814,191 | $14,943,000 | 0.64% |
| PFM Health Sciences, LP | 3,013,712 | $16,003,000 | 0.58% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,710,000 | 0.34% |
| Yiheng Capital Management, L.P. | 997,857 | $5,299,000 | 0.33% |
| Bellevue Group AG | 3,627,280 | $19,261,000 | 0.28% |
| BVF INC/IL | 361,824 | $1,921,000 | 0.08% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $13,275,000 | 0.07% |